$ATNM interim data readouts consistently show 6x number of evaluable patients available for primary endpoint readout vs. control arm. Only 2x of control arm that achieve 6 month durable complete remission are required to meet primary endpoint. Yes, you read this correctly.
  • 11
11 Likes